Invokana Drug Interactions: 65 Major, 481 Moderate
Invokana (Canagliflozin) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Invokana. Always confirm against the full prescribing information.
100 interactions
Abrocitinib
The serum concentration of Canagliflozin can be increased when it is combined with Abrocitinib.
Level 2 evidence
Acarbose
Canagliflozin may increase the hypoglycemic activities of Acarbose.
Level 2 evidence
Acebutolol
The therapeutic efficacy of Canagliflozin can be increased when used in combination with Acebutolol.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Canagliflozin.
Level 1 evidence
Adagrasib
The serum concentration of Canagliflozin can be increased when it is combined with Adagrasib.
Level 2 evidence
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Canagliflozin.
Level 2 evidence
Alclometasone
The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Canagliflozin.
Level 1 evidence
Alogliptin
Canagliflozin may increase the hypoglycemic activities of Alogliptin.
Level 2 evidence
Ambrisentan
The serum concentration of Ambrisentan can be increased when it is combined with Canagliflozin.
Level 2 evidence
Amcinonide
The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Canagliflozin.
Level 1 evidence
Amikacin
Canagliflozin may decrease the excretion rate of Amikacin which could result in a higher serum level.
Level 2 evidence
Aminosalicylic acid
Aminosalicylic acid may increase the hypoglycemic activities of Canagliflozin.
Level 2 evidence
Enter your NPI to unlock 5 major interactions for Invokana
Invokana (Canagliflozin) has 1129 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Invokana (Canagliflozin) has 65 major, 481 moderate, and 583 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Invokana. Always confirm against the full prescribing information.